Scroll Back to Top
Accessibility
Accessibility

OmniSeq INSIGHT, Solid Tumor NGS Panel (DNA and RNA)

CPT 81459; 88360(x2); 88381

Test Details

Cancer Type

Bladder, Brain, Breast, Cervical, Colorectal cancer (CRC), Endometrial, Gastroesophageal, Gastrointestinal stromal tumor (GIST), Glioblastoma, Head and neck, Lung, Melanoma, Non-small cell lung cancer, Ovarian, Pan-cancer, Prostate, Skin, Squamous cell carcinoma of the head and neck (SCCHN), Thyroid

Technology Used

NGS

Turnaround Time

12 - 14 days

Test Requisition Form How to Order

Use

OmniSeq® INSIGHT is a next generation sequencing-based in vitro diagnostic device for the detection of genomic variants, signatures, and immune gene expression in formulin-fixed paraffin-embedded (FFPE) tumor tissue. DNA is sequenced to detect small variants; single and multi-nucleotide substitutions, insertions, deletions and indels, and copy number alterations (CNA) gains and losses in 523 genes, including 14 genes leading to homologous recombination repair defects (HRR/HRD), as well as analysis of microsatellite instability (MSI) and tumor mutational burden (TMB) signatures. RNA is also sequenced for detection of fusions and splice site variants in 55 genes in addition to mRNA expression in 64 immune genes. The resultant information, along with PD-L1 protein expression by immunohistochemistry (IHC), is intended for use by qualified health care professionals in accordance with practice guidelines and standards in oncology for patients with solid neoplasms.

Special Instructions

OmniSeq® INSIGHT is orderable through Labcorp Oncology. For more information please visit oncology.labcorp.com/cancer-care-team/test-menu/omniseq-insight. Note: When submitting a sample, the pathology report, primary tumor type and state of disease are required.

Methodology

OmniSeq® INSIGHT is a next generation sequencing-based in vitro diagnostic device; PD-L1 by immunohistochemistry

Related Documents

For more information, please view the literature below.

Test Requisition Form - Gene Profiling Assays

OmniSeq® INSIGHT Gene List

OmniSeq® INSIGHT Brochure

Sample Report – Lung

    Specimen Requirements

    Information on collection, storage, and volume

    Specimen

    Formalin-fixed, paraffin-embedded (FFPE) tissue block or slides

    Volume

    Block is preferred, or send 20 unbaked, positively charged, unstained slides cut at 5µM plus 1 H&E.

    Minimum Volume

    20 unbaked, positively charged, unstained slides cut at 5µM

    Container

    Paraffin block or slides

    Storage Instructions

    FFPE blocks are stored at room temperature and shipped with no special precautions, except when daily outside temperatures exceed 35°C, and then ship with cool packs to avoid paraffin meltdown.

    Causes for Rejection

    Tumor block containing insufficient tumor tissue or no tumor; broken or stained slides; decalicified bone biopsies; cytology smears or samples from hematologic malignancies. Specimens with very small amounts of tumor and/or less than requested number of slides will be accepted with the caveat that complete testing may not be possible.

    Collection

    Blocks and unstained slides (USS) must at a minimum be labeled with the pathology case number and block identification number.

    Request Supplies